Skip to content

Effects of Graston Versus Myofascial Release Technique in Patients With Cervicogenic Headache

Effects of Graston Versus Myofascial Release Technique on Pain, Range of Motion and Functional Disability in Patients With Cervicogenic Headache

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07724639
Enrollment
48
Registered
2026-07-24
Start date
2026-07-01
Completion date
2026-12-30
Last updated
2026-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervicogenic Headache

Keywords

Cervicogenic Headache, Graston Technique, Neck Disability Index, Numeric Pain Rating Scale, Myofascial Release Therapy, Range of Motion

Brief summary

Cervicogenic Headache (CGH) is a painful condition that has pronounced impacts on quality and activity of daily lives. It is often associated with decreased mobility, muscular tightness, and postural deviations. When neck muscles become tight, weak, or irritated, they change the way the neck moves and put pressure on nearby joints and nerves. This pressure delivers pain signals to the head, causing a Cervicogenic headache.

Detailed description

The aim of this study is to compare the effects of the Graston Technique and Myofascial Release in reducing pain, improving cervical range of motion, and decreasing functional disability in patients with Cervicogenic headache. This study will be a randomized control trial and will be take place at Sehat Medical Complex, lake city branch, Lahore. Non-probability convenience sampling will be used to collect data. Sample size of ( ) subjects with age group between 18-40 years will be taken. Data will be collected from the patients having present complaint of Cervicogenic headache. Outcome measures will be assessed using numeric pain rating scale (NPRS) for pain, Neck Disability Index (NDI) to measure neck related disability, Headache Disability Index (HDI) to assess the impact of headaches on daily activities and emotional well-being and Goniometer for assessing range of motions. An informed consent will be taken and subjects will be selected on basis of inclusion and exclusion criteria. They will be divided into two groups by random number generator. One group will receive Graston technique and other myofascial release as a treatment while both groups will be receiving conventional treatment alongside. Outcome measures will be measured at baseline and after 4 weeks. Data analysis will be done by SPSS version 21.

Interventions

* Manual release applied to same regions as above using sustained pressure and fascial stretch. * Duration: 7-10 minutes per session. * Frequency: 2-3 sessions per week, for 4 weeks.

OTHERGraston technique

* Applied to: Sternocleidomastoid, Upper trapezius, Levator scapulae, Suboccipitals and cervical paraspinals. * Duration: 5-7 minutes per session, depending on patient tolerance and therapist assessment. * Frequency: 2-3 sessions per week, for 4 weeks

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Males and females between age 18-40 years \[A30.1\]of age with Cervicogenic Headache * Diagnosed with Cervicogenic headache according to ICHD-3 criteria (3) * Presence of active myofascial trigger points in the SCM and upper trapezius and subocvcipital levator scapuli (confirmed \[A31.1\]via palpation and referred pain) simens \[A32.1\]criteria * Positive Cervical Flexion Rotation Test

Exclusion criteria

* Any history of cervical trauma, fracture, or recent surgery. * Diagnosis of migraine, tension-type headache, or cluster headache (9). * Any cervical spine pathology e.g. cervical myelopathies and arthropathies. * Pregnant or lactating women. * Skin conditions or open wounds that contraindicate use of Graston tools e.g. open wounds, skin infections and burns etc.

Design outcomes

Primary

MeasureTime frameDescription
Neck Disability Index (NDI)upto 4 weeks
Numeric Pain Rating Scale (NPRS)upto 4 weeksPatient level of pain will be assessed using this scale. This scale ranges from 0 to 10. 0 indicates "no pain" and 10 indicates "worst pain".

Secondary

MeasureTime frameDescription
Universal Goniometer (UG)upto 4 weeksThe range of motion will be measured using universal goniometer that has an inter-rater reliability (ICC2, 2 = 0.79 to 0.92) for cervical region
Global Rating of Change (GROC) scaleupto 4 weeksGlobal Rating of Change (GROC) scale

Contacts

CONTACTSumrod Akram
samrood.akram@riphah.edu.pk03324806143
PRINCIPAL_INVESTIGATORSofia Rahim, MSPT*

Riphah International University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 25, 2026